ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)

ClinicalTrials.gov ID: NCT02844465

Public ClinicalTrials.gov record NCT02844465. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Stereotactic Laser Ablation for Temporal Lobe Epilepsy

Study identification

NCT ID
NCT02844465
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
MedtronicNeuro
Industry
Enrollment
167 participants

Conditions and interventions

Interventions

  • Visualase MRI-Guided Laser Ablation Device

Device

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2016
Primary completion
Dec 10, 2023
Completion
Dec 10, 2023
Last update posted
Jan 16, 2025

2016 – 2023

United States locations

U.S. sites
23
U.S. states
20
U.S. cities
23
Facility City State ZIP Site status
Hoag Memorial Hospital Presbyterian Newport Beach California 92688
Stanford University Palo Alto California 94305
University of California, San Francisco San Francisco California 94143
University of Colorado Anschutz Medical Campus Aurora Colorado 80045
University of Miami Miami Florida 33136
Emory University Atlanta Georgia 30322
University of Chicago Chicago Illinois 60637
Indiana University Indianapolis Indiana 46202
University of Louisville Hospital Louisville Kentucky 40202
Johns Hopkins University Baltimore Maryland 21287
Henry Ford Health System Detroit Michigan 48202
Mayo Clinic Rochester Minnesota 55905
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03766
Rutgers University - Robert Wood Johnson Medical School New Brunswick New Jersey 08901
Northwell Health Great Neck New York 11021
Columbia University Medical Center New York New York 10032
Wake Forest Baptist Health Winston-Salem North Carolina 27157
Ohio Health Research Institute Columbus Ohio 43214
Oregon Health & University Science Portland Oregon 97239
Thomas Jefferson University Philadelphia Pennsylvania 19107
The University of Texas Health Science Center at Houston Houston Texas 77030
University of Virginia Charlottesville Virginia 22903
University of Washington Harborview Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02844465, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 16, 2025 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02844465 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →